SCHEMBL5670682

SCHEMBL5670682

NC(=O)C1=CCCCCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 6/20 0.55
HDAC4 P56524 2/20 0.55
HDAC8 Q9BY41 2/20 0.55
HDAC6 Q9UBN7 2/20 0.55
HDAC1 Q13547 5/20 0.47
HDAC3 O15379 4/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
CTSK P43235 1/20 0.44
CCR2 P41597 1/20 0.41
GABRR1 P24046 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
SIRT3 Q9NTG7 1/20 0.33
KDM1A O60341 1/20 0.33
BTK Q06187 1/20 0.33
HSD11B1 P28845 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4936512 1.00 HDAC2 (0.55) HDAC2HDAC4HDAC8HDAC6HDAC1
SCHEMBL2453335 1.00 HDAC2 (0.55) HDAC2HDAC4HDAC8HDAC6HDAC1
SCHEMBL1792368 1.00 HDAC2 (0.55) HDAC2HDAC4HDAC8HDAC6HDAC1
SCHEMBL5670679 1.00 HDAC2 (0.55) HDAC2HDAC4HDAC8HDAC6HDAC1
SCHEMBL8607580 1.00 HDAC2 (0.55) HDAC2HDAC4HDAC8HDAC6HDAC1
SCHEMBL1258049 0.98
SCHEMBL405604 0.91
SCHEMBL29035906 0.81 HDAC2 (0.59) HDAC2HDAC4HDAC8HDAC6HDAC1
SCHEMBL28986665 0.81 HDAC2 (0.59) HDAC2HDAC4HDAC8HDAC6HDAC1
SCHEMBL27412319 0.81 HDAC2 (0.59) HDAC2HDAC4HDAC8HDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1886124-A Method for inhibiting production of remnant lipoproteins JAPAN TOBACCO INC (JP) 2006-12-27 CN claimed
EP-1670446-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2006-06-21 EP claimed
WO-2005030185-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2005-04-07 WO claimed
CN-103330703-A Method of inhibiting remnant lipoprotein production JAPAN TOBACCO INC 2013-10-02 CN disclosed
CN-101342162-A Method of inhibiting remnant lipoprotein production JAPAN TOBACCO INC (JP) 2009-01-14 CN disclosed
CN-1886124-A Method for inhibiting production of remnant lipoproteins JAPAN TOBACCO INC (JP) 2006-12-27 CN disclosed
CN-1863511-A Dosage forms providing controlled release cholesteryl ester transfer protein inhibitors and immediate release HMG-CoA reductase inhibitors PFIZER (US) 2006-11-15 CN disclosed
EP-1670446-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2006-06-21 EP disclosed
CN-1728995-A Dosage forms comprising a cetp inhibitor and an HMG-CoA reductase inhibitor PFIZER PROD INC (US) 2006-02-01 CN disclosed
WO-2005030185-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2005-04-07 WO disclosed
US-4835312-A Production process of N-substituted amide compounds MITSUI CHEMICALS, INCORPORATED (JP) 1989-05-30 US disclosed